Title : LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.

Pub. Date : 2022 Jan 4

PMID : 34982278






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Importantly, LPA significantly promoted the proliferation and migration of LPA3-overexpressing ovarian cancer cells, while the LPA-induced actions blocked by Ki16425, a LPAR1/3 antagonist treated, and LPA3-shRNA transfected. 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid lysophosphatidic acid receptor 3 Homo sapiens